Search Results - "Topp M"

Ultrashort pulse generation by Nd3+:glass and Nd3+:YAG lasers.

Authors: Choi, K. J. Topp, M. R.

Source: Journal of the Optical Society of America; May 1981, Vol. 71, p520-524, 5p

Time-resolved absorption spectroscopy in the 10-12-sec range.

Authors: Topp, M. R.

Source: Journal of Applied Physics; August 1971, Vol. 42, p3415-3419, 5p

Industrial and medical uses of ultrasonic atomizers.

Authors: Topp, M. N. Eisenklam, P.

Source: Ultrasonics; May 1972, Vol. 10, p127-133, 7p

New scheme for ultrashort-pulsed Nd3+.

Authors: Boczar, B. P. Topp, M. R.

Source: Applied Optics; June 1 1983, Vol. 22, p1611-1613, 3p

Method for the remote determination of the displacement amplitude of an ultrasonic horn.

Authors: Topp, M. N.

Source: Journal of Physics. E, Scientific Instruments.; September 1970, Vol. 3, p739-740, 2p

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Authors: Engert A Haverkamp H Kobe C et al.

Source: Lancet. 5/12/2012, Vol. 379 Issue 9828, p1791-1799. 9p.

Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study.

Authors: Platt MJ Cans C Johnson A et al.

Source: Lancet. 1/6/2007, Vol. 369 Issue 9555, p43-50. 8p.

Cerebral palsy births in eastern Denmark, 1987--90: implications for neonatal care.

Authors: Topp, Monica Uldall, Peter Topp, M et al.

Source: Paediatric & Perinatal Epidemiology. Jul2001, Vol. 15 Issue 3, p271-277. 7p.

OP0024 Use of novel patient-derived xenografts and molecular subtyping to improve precision medicine in high-grade serous ovarian cancer.

Authors: Heong, V. Topp, M. Rutkowski, R. et al.

Source: European Journal of Cancer. May2014 Supplement 4, Vol. 50, pe9-e9. 1p.

CHANGES IN MULTIPLE LIVE BIRTHS AND CEREBRAL PALSY CHILDREN OVER TIME IN EUROPE (1980-1996).

Authors: Cans, C. Topp, M. Gliniabaua, S. et al.

Source: Journal of Epidemiology & Community Health. Aug2004 Supplement 1, Vol. 58, pA13-A13. 1/3p.

The Sensitivity of Rapid Tests for SARS-CoV-2 Antigen: Association With Clinical Manifestations, Viral Load, and Sublines: Association with clinical manifestations, viral load, and sublines.

Authors: Knies, K. Wagenhäuser, I. Hofmann, D. et al.

Source: Deutsches Ärzteblatt International. 11/10/2023, Vol. 120 Issue 45, p763-764. 2p.

Auto-SCT in severe paraproteinemic neuropathy.

Authors: Hummel, H. D. Rath, J. C. Wiendl, H. et al.

Source: Bone Marrow Transplantation. Mar2011, Vol. 46 Issue 3, p457-459. 3p. 1 Chart.

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.

Authors: Wang, M. Munoz, J. Goy, A. et al.

Source: New England Journal of Medicine. 4/2/2020, Vol. 382 Issue 14, p1331-1342. 12p.

Case gender and severity in cerebral palsy varies with intrauterine growth.

Authors: Jarvis, S. Glinianaia, S. V. Arnaud, C. et al.

Source: Archives of Disease in Childhood. May2005, Vol. 90 Issue 5, p474-479. 6p. 3 Charts, 2 Graphs.

Electronic coupling and conformational barrier crossing of 9,9’-bifluorenyl studied in a supersonic jet.

Authors: Smith, P. G. Gnanakaran, S. Kaziska, A. J. et al.

Source: Journal of Chemical Physics. 3/1/1994, Vol. 100 Issue 5, p3384. 10p. 4 Diagrams, 3 Charts, 6 Graphs.

Second-line treatment with tafasitamab and lenalidomide for relapsed/refractory primary cutaneous diffuse large B-cell lymphoma.

Authors: Wobser M Rosenwald A Eisele F et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Aug; Vol. 67 (9), pp. 1990-1993. Date of Electronic Publication: 2026 May 22.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Update on the management of leptomeningeal disease in solid organ malignancy: Systemic, intrathecal and novel therapies.

Authors: Fisher S Topp M Airth A et al.

Source: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2026 Sep; Vol. 151, pp. 112076. Date of Electronic Publication: 2026 May 15.

Publication Type: Journal Article; Systematic Review; Review

Journal Info: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9433352 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2653 (Electronic) Linking ISSN: 09675868 NLM ISO Abbreviation: J Clin Neurosci Subsets: MEDLINE

828 | TRIAL IN PROGRESS: PEMBROLIZUMAB IN COMBINATION WITH SALVAGE CHEMOTHERAPY FOR FIRST‐RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (PEMBRO‐CORE).

Authors: Tharmaseelan, H. Gillessen, S. Bühnen, I. et al.

Source: Hematological oncology 2025 Supplement; Vol. 43.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232

280 | GLOFITAMAB COMBINED WITH R‐CHOP OR POLA‐R‐CHP IN PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA: FINAL RESULTS FROM THE NP40126 STUDY.

Authors: Topp, M. S. Tani, M. Dickinson, M. et al.

Source: Hematological oncology 2025 Supplement; Vol. 43.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232

103 | A PHASE 1 STUDY OF KITE‐363 ANTI‐CD19/CD20 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) B‐CELL LYMPHOMA.

Authors: Dahiya, S. Ulrickson, M. L. Topp, M. S. et al.

Source: Hematological oncology 2025 Supplement; Vol. 43.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232